Virtual drug repurposing study against SARS-CoV-2 TMPRSS2 target
Article
[키워드] approach
approved drug
average
binding
binding energy
binding free energy
camostat
cause
clinical investigation
Clinical studies
Compound
COVID-19
COVID19
develop
disease
docking
drug
Drug repurposing
Drug screening
FDA
identify
in vitro
in vivo
include
inhibitor
Ligand
MD simulation
molecular
molecular docking
new coronavirus SARS-CoV-2
NIH
positive control
residue
SARS-CoV-2
scored
screened
small molecule
target
TMPRSS2
TMPRSS2 inhibitor
transmembrane serine protease
Vaccine
[DOI] 10.3906/biy-2005-112 PMC 바로가기 [Article Type] Article
[DOI] 10.3906/biy-2005-112 PMC 바로가기 [Article Type] Article